NEW YORK, Jan. 26 (UPI) -- Drugmaker Pfizer announced Monday it had reached a $68 billion cash-and-stock agreement to merge with U.S. rival Wyeth.
COLLEGEVILLE, Pa., July 30 (UPI) -- Wyeth said Monday its new contraceptive pill Lybrel is now available in U.S. pharmacies.
COLLEGEVILLE, Pa., May 14 (UPI) -- Wyeth said Monday it filed an application to the European Medicines Agency for approval of methylnaltrexone for opioid-induced constipation.
MADISON, N.J., April 27 (UPI) -- U.S. pharmaceutical firm Wyeth said Thursday its chief financial officer will leave the company at the end of June.
BRISTOL, Tenn., July 6 (UPI) -- King and Wyeth said Thursday they revamped their deal for co-promoting Altace with King to assume full responsibility in 2007.
WASHINGTON, Jan. 25 (UPI) -- Primatene Mist, an inhaled asthma drug on the U.S. market since the 1950s, looks to be reformulated given a federal panel's ruling, a report said Wednesday.
NEW YORK, Jan. 3 (UPI) -- Wyeth and Trubion Pharmaceuticals have reportedly entered a pact to develop antibody drugs.
WASHINGTON, Dec. 6 (UPI) -- A Food and Drug Administration employee who questioned the safety of Wyeth's heartworm drug was investigated based on the drugmaker's complaint, reports said.
MADISON, N.J., Dec. 2 (UPI) -- Wyeth said Friday it has been cleared by the Federal Trade Commission to settle its patent dispute with Teva.
MADISON, N.J., June 20 (UPI) -- Drugmaker Wyeth Ltd. of New Jersey plans to shrink and restructure its main sales force.
